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reported as severe. For current dry eye condition, mean utilities
for these groups were 0.72 for self-reported mild to moderate
and 0.61 for self-reported severe. CONCLUSIONS: Utilities for
dry eye were in the range of conditions accepted as lowering
health utilities. Severe dry eye utilities were similar to those
reported for dialysis and severe angina. Findings highlight the
impact of dry eye on patients.
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OBJECTIVE: Ophthalmologists have to face various acute or
chronic painful diseases. They miss speciﬁc tools assessing ocular
pain. Our objective was to develop and validate a tool to quickly
and precisely describe patient’s complaint, measure pain inten-
sity and elicit possible causes. METHODS: Different types of
quantiﬁcation and description of pain identiﬁed from the litera-
ture were proposed to 20 patients suffering from acute or chronic
painful ophthalmic diseases. A questionnaire was developed, val-
idated by an Advisory Committee (AC) and tested with 8 other
patients. The pilot questionnaire was produced and validated by
the AC. A cross-sectional, observational study was carried out
to validate the questionnaire for a use in clinical practice and to
provide a typology of painful ocular pathologies. The question-
naire was completed by 536 consecutive patients presenting with
pain complaint in 43 centres. The clinicians completed a medical
form and assessed the questionnaire’s usefulness and feasibility
in clinical practice. RESULTS: The test questionnaire was devel-
oped taking into account the preference given by patients to
visual analogous or graduated scales to quantify pain, and to pic-
tograms to describe pain. This test version was considered valid
and easy to use, except for the emotional descriptors of pain.
The pilot questionnaire contained ﬁve sections: “General
Health”, “Eyes and eyesight”, “Pain”, “Pain relief”, “Pic-
tograms and sensorial descriptors”. A description of pain char-
acteristics was provided for the most frequent painful diseases,
including traumatisms (183), ocular surface diseases (71), cornea
pathologies (58). A total of 27 ophthalmologists evaluated the
questionnaire and 78% of them considered it helpful for patient
management. CONCLUSION: The ODEON® questionnaire is
a unique, promising tool designed for use in clinical practice to
allow patients with ocular pain to comprehensively quantify and
describe their pain in a standardised format. Further work is
needed to establish speciﬁc recommendations.
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OBJECTIVES: To compare the results of a prospective cost-
beneﬁt analysis (CBA) of the South Carolina Palmetto Poison
Center (PPC) using Bayesian and frequentist (inferential) statis-
tical approaches to estimation. METHODS: Results from a cost-
beneﬁt analysis of a statewide poison control center were used
in this analysis. The CBA was conducted based on a follow-up
survey of 652 callers to the PPC who were recommended for
home management of their suspected poisoning exposure. A
payor perspective was taken and costs included direct costs. Ben-
eﬁts were measured as direct medical costs avoided (e.g. emer-
gency department visit, ambulance service, physician visit) by the
use of the PPC. A series of decision analytic models were con-
structed and analyzed separately with frequentist and Bayesian
statistical methods. Data from a similar CBA of the PPC con-
ducted in 1998 was used to obtain the “prior” information
needed for the Bayesian analysis. BC ratios using the two
approaches were compared and their interpretations explored.
RESULTS: Calculation of BC ratios using Bayesian and fre-
quentist approaches yielded similar measures. The BC ratio was
7.77 in the frequentist approach with a 95% CI of (6.93, 8.61)
and 7.42 in the Bayesian approach with a 95% credible interval
of (5.46, 9.38). See the abstract titled “Cost-Beneﬁcial Accept-
ability Curves: Calculation and Comparison between Frequen-
tist and Bayesian Statistical Approaches in Cost-Beneﬁt
Analysis” for the detailed CBA data and description. CON-
CLUSIONS: The PPC is cost-beneﬁcial over a reasonable range
of cost and beneﬁt values. Results are similar between the fre-
quentist and Bayesian approaches, although interpretation of the
two approaches differs signiﬁcantly.
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OBJECTIVES: To evaluate the inﬂuence of an evidence based
guideline for clinical nutrition on direct cost for enteral and par-
enteral nutrition. METHODS: Annual cost for enteral and par-
enteral nutrition has been analysed. An evidence based guideline
for clinical nutrition was developed in the hospital by a multi-
disciplinary team consisting of medical doctors, nurses, dieticians
and pharmacists. In general a guideline is a comprehensive
approach to the best available evidence for clinical nutrition
(enteral nutrition should be used when ever possible). The guide-
line was then implemented in the hospital by teaching nurses and
doctors. One year after introduction of the guideline the annual
cost were analysed. RESULTS: In 2003 the cost for parenteral
nutrition were €86.908, and for enteral nutrition €16.273. After
establishing the guideline the cost were reduced especially for
parenteral nutrition (parenteral nutrition €52.245, enteral nutri-
tion €16.092). The savings in 2004 were €34.844, (number of
cases and severity of illness detected by disease staging TM
(medstat group) did not change) CONCLUSIONS: The cost
reduction for clinical nutrition could be inﬂuenced by several
factors: 1) It is possible that the regained awareness of costs have
inﬂuenced the behaviour of the clinicians independent of the
guideline, and 2) The implementation of the guideline lead to an
improved knowledge of the clinicians in clinical nutrition and
reduced variance in individual decision making. Thus nutritional
status improved whereas costs were lowered. Further studies are
needed to detect changes in nutritional status of patients 
after having established a guideline. A study has been initiated
(Nutricor).
